The Banking and Strategy Initiative

Chillin' out till it needs to be funded

Category Archives: Dealbook

Its Monday Again! A new Godzilla for $90 mln and The snowplough reports for Retail sales , The Week Ahead 19th May -23rd May, 2014 (US Economy and Markets )

It was definitely Asia’s week as NaMo swept India’s General Elections Deal markets were busy trading down Astrazeneca on Monday morning even as Europe opened to another bout of misery … Continue reading

May 20, 2014

US Mid Week Trading Report: Amazon posts close to $20 Bln in Topline, Apple lets iPad slide, Pharma gets big deal traction in earnings season US:SBUX, US:AMZN, US:AAPL, US:NFLX, US:CAT, US:AZN, US:NVS

More brew from the Seahawk line Seattle’s Best (as an Adjective clause, not just the coffee ) may well be Starbucks yet as it scored another 6% in comparable sales … Continue reading

April 25, 2014

Deal Insight: InBev catches Grupo Modelo SAB for $20B

Anheuser Busch uis finally in ownership of 100% of Corona Extra. The larges star cast in the deal also features Constellation Brands, that runs the Distribution franchise and Anheuser Busch … Continue reading

June 29, 2012

A $16.2B inspired Walgreens snags Boots | The Deal Economy

This Draft was no different with Boots CEO Pessina managing to land a third of the 8% Walgreens equity swapped in exchange for this all share deal. the 8% equity … Continue reading

June 19, 2012

Facebook Institutional Demand can wait – Facebook uses up greenshoe as price drops below $34 | Deal Insight

According to informed sources posted by the Investment Bankers to Facebook, the first day of trading hit a few snags apart from the Trading system design for retail orders on … Continue reading

May 21, 2012

Are you following the Facebook IPO? | Deal Insight

Latest S-1 (S-1/A) filed with SEC The news is Mark zucked’rberg is not very camera friendly. The Roadshow shmoozing got off to a rocky start in front of the Sheraton … Continue reading

May 7, 2012

The Deal Economy (Midweek brush) : Oaktree IPO priced, yelp’s yellow reviews don’t help, I am not iPad

I am not an iPad? Drug maker and soon to be Genomics major Roche brought in a new watermark mid week to compare laboratory experiments and start ups to on … Continue reading

April 11, 2012

The Deal Economy: The Avon CEO is a living poison pill, hedge funds return 5%

Hedge funds return their best in Q1 In what may redefine the Hedge funds industry and decide what kind of inflows the sector gets from 2013, the Hedge funds signed … Continue reading

April 10, 2012

The Deal Economy: A mobile app for Facebook, 10k jobs cut at Sony, Burger King lists again

Burger King’s plans for a reverse merger My favourite meat patty just got back into the tinsel town of scrips trying to go public again. Burger King’s previous attempts at … Continue reading

April 9, 2012